Ronald S Veazey Selected Research

N(alpha)- (n- nonanoyl)- desSer(1)- (thioproline(2),cyclohexylglycine(3))- RANTES

5/2009

Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald S Veazey Research Topics

Disease

44	Infections 03/2022 - 03/2003
12	Viremia 12/2021 - 11/2003
12	HIV Infections (HIV Infection) 12/2021 - 11/2002
5	Disease Progression 01/2021 - 10/2004
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2013 - 11/2004
4	Inflammation (Inflammations) 01/2021 - 01/2012
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2021
2	Persistent Infection 01/2020 - 12/2010
2	Tetanus 01/2018 - 09/2014
1	COVID-19 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Chronic Disease (Chronic Diseases) 12/2019
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Pain (Aches) 01/2017
1	Herpes Genitalis (Genital Herpes) 01/2017
1	Neonatal herpes 01/2017
1	Bacterial Infections (Bacterial Infection) 12/2015
1	Body Weight (Weight, Body) 11/2013
1	Celiac Disease (Celiac Sprue) 04/2013
1	Amyloidosis 11/2012
1	Callosities 11/2012
1	Fibroma (Fibromatosis) 05/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 02/2012
1	Bacterial Vaginosis 01/2012
1	Breakthrough Infections 01/2011
1	Foreign Bodies (Foreign Body) 11/2007

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 01/2021 - 11/2002
8	AntigensIBA 01/2020 - 06/2013
7	CytokinesIBA 01/2021 - 04/2003
4	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2012
4	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2014
4	Anti-Infective Agents (Microbicides)IBA 05/2012 - 03/2003
3	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2019
3	EpitopesIBA 01/2020 - 01/2006
3	AntibodiesIBA 01/2020 - 07/2013
3	Sucrose (Saccharose)IBA 12/2013 - 10/2005
3	Antiviral Agents (Antivirals)IBA 11/2013 - 01/2012
3	Maraviroc FDA Link 05/2012 - 09/2010
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 04/2013
2	Monoclonal AntibodiesIBA 01/2021 - 03/2003
2	Immunoglobulin G (IgG)IBA 01/2020 - 11/2013
2	Neutralizing AntibodiesIBA 12/2013 - 11/2013
2	Biological ProductsIBA 11/2013 - 05/2012
2	Pharmaceutical PreparationsIBA 05/2009 - 06/2005
2	CMPD 167IBA 10/2004 - 11/2003
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	N- (2,6- dichlorobenzoyl)- 4- (2',6'- bismethoxyphenyl)phenylalanineIBA 01/2021
1	CR3022IBA 01/2021
1	emtricitabine tenofovir alafenamideIBA 01/2021
1	Viral DNAIBA 01/2021
1	IntegrinsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	MucinsIBA 01/2020
1	Viral RNAIBA 01/2019
1	3-ingenyl angelateIBA 12/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2015
1	MannansIBA 12/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2014
1	Interferon-gamma (Interferon, gamma)IBA 11/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2014
1	Reverse Transcriptase InhibitorsIBA 01/2014
1	L870812IBA 01/2014
1	RacivirIBA 01/2014
1	Integrase InhibitorsIBA 01/2014
1	Ethanol (Ethyl Alcohol)IBA 12/2013
1	Bromodeoxyuridine (BrdU)IBA 11/2013
1	Immunologic Factors (Immunomodulators)IBA 11/2013
1	Glutens (Glutelin)IBA 04/2013
1	Interleukin-22 (IL-22)IBA 04/2013
1	Amyloid (Amyloid Fibrils)IBA 11/2012
1	Congo RedIBA 11/2012
1	Coloring Agents (Dyes)IBA 11/2012
1	GlycogenIBA 01/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2012
1	lipopolysaccharide-binding proteinIBA 01/2012
1	ChitinasesIBA 01/2012
1	AerosolsIBA 08/2011
1	ChemokinesIBA 03/2011
1	GelsIBA 01/2011
1	Programmed Cell Death 1 ReceptorIBA 12/2010
1	16S Ribosomal RNAIBA 02/2010
1	CC ChemokinesIBA 05/2009
1	6P4-RANTESIBA 05/2009
1	5P12-RANTESIBA 05/2009
1	N(alpha)- (n- nonanoyl)- desSer(1)- (thioproline(2),cyclohexylglycine(3))- RANTESIBA 05/2009
1	ISCOMsIBA 11/2006
1	Mamu-A 02 antigenIBA 01/2006
1	Histocompatibility Antigens Class IIBA 01/2006
1	BMS-378806IBA 11/2005

Therapy/Procedure

8	Therapeutics 12/2021 - 11/2002
4	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 09/2004
1	Aftercare (After-Treatment) 01/2021
1	Art Therapy 01/2021
1	Chemoprevention 03/2009
1	Catheters 11/2007
1	Transplantation 06/2005